Theranostic Nucleic Acid Binding Nanoprobe Exerts Anti-inflammatory and Cytoprotective Effects in Ischemic Injury

Extracellular nucleic acids are proinflammatory molecules that have been implicated in a diverse range of diseases. We report here the development of a multivalent nucleic acid scavenging nanoprobe, where the fluorochrome thiazole orange (TO) is conjugated to a polymeric 40 kDa dextran carrier. Dext...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Theranostics 2017-01, Vol.7 (4), p.814-825
Hauptverfasser: Chen, Howard H, Yuan, Hushan, Cho, Hoonsung, Feng, Yan, Ngoy, Soeun, Kumar, Anand T N, Liao, Ronglih, Chao, Wei, Josephson, Lee, Sosnovik, David E
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 825
container_issue 4
container_start_page 814
container_title Theranostics
container_volume 7
creator Chen, Howard H
Yuan, Hushan
Cho, Hoonsung
Feng, Yan
Ngoy, Soeun
Kumar, Anand T N
Liao, Ronglih
Chao, Wei
Josephson, Lee
Sosnovik, David E
description Extracellular nucleic acids are proinflammatory molecules that have been implicated in a diverse range of diseases. We report here the development of a multivalent nucleic acid scavenging nanoprobe, where the fluorochrome thiazole orange (TO) is conjugated to a polymeric 40 kDa dextran carrier. Dextran-TO (Dex-TO) has nanomolar affinity for mammalian and bacterial nucleic acids and attenuates the production of inflammatory cytokines from activated macrophages exposed to DNA and RNA. Mice with myocardial ischemia reperfusion that were treated with Dex-TO showed a decrease in myocardial macrophage infiltration at 24 hours (p
doi_str_mv 10.7150/thno.17366
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5381246</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1884891847</sourcerecordid><originalsourceid>FETCH-LOGICAL-c378t-1ef3cc1feec1fea6644ce8a0badf1dc43f08a700338a120ea979aaa5a91fdb813</originalsourceid><addsrcrecordid>eNpVkUFrGzEQhUVoaILjS39A0bEUNpFW613tpeAaNzEY95KexVg7ihV2JUfShvrfV26ckMxhZuB9vBl4hHzh7LrhM3aTds5f80bU9Rm55FLIoqkr9undfkGmMT6yXBUrW95-Jhdl1ko-qy_J0_0OAzgfk9V0M-oe85xr29Gf1nXWPdBNVvfBb5Eu_2JIkc5dsoV1podhgOTDgYLr6OKQjlhCnexzZo3JW6TW0VXUOxyy7co9juFwRc4N9BGnpzkhf34t7xd3xfr37WoxXxdaNDIVHI3QmhvEY4O6riqNEtgWOsM7XQnDJDSMCSGBlwyhbVoAmEHLTbeVXEzIjxff_bgdsNPoUoBe7YMdIByUB6s-Ks7u1IN_VjMheVnV2eDbySD4pxFjUoONGvseHPoxKi5lJVsuqyaj319QHXyMAc3bGc7UMSZ1jEn9jynDX98_9oa-hiL-ASFAkj0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1884891847</pqid></control><display><type>article</type><title>Theranostic Nucleic Acid Binding Nanoprobe Exerts Anti-inflammatory and Cytoprotective Effects in Ischemic Injury</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>PubMed Central</source><creator>Chen, Howard H ; Yuan, Hushan ; Cho, Hoonsung ; Feng, Yan ; Ngoy, Soeun ; Kumar, Anand T N ; Liao, Ronglih ; Chao, Wei ; Josephson, Lee ; Sosnovik, David E</creator><creatorcontrib>Chen, Howard H ; Yuan, Hushan ; Cho, Hoonsung ; Feng, Yan ; Ngoy, Soeun ; Kumar, Anand T N ; Liao, Ronglih ; Chao, Wei ; Josephson, Lee ; Sosnovik, David E</creatorcontrib><description>Extracellular nucleic acids are proinflammatory molecules that have been implicated in a diverse range of diseases. We report here the development of a multivalent nucleic acid scavenging nanoprobe, where the fluorochrome thiazole orange (TO) is conjugated to a polymeric 40 kDa dextran carrier. Dextran-TO (Dex-TO) has nanomolar affinity for mammalian and bacterial nucleic acids and attenuates the production of inflammatory cytokines from activated macrophages exposed to DNA and RNA. Mice with myocardial ischemia reperfusion that were treated with Dex-TO showed a decrease in myocardial macrophage infiltration at 24 hours (p&lt;0.05) and a decrease in infarct size (18% ± 9%, p&lt;0.01) on day 7. Dex-TO allows sites of injury to be identified with fluorescence imaging, while simultaneously exerting an anti-inflammatory and cytoprotective effect. Dex-TO could be of significant diagnostic and therapeutic (theranostic) utility in a broad range of conditions including ischemia, trauma, burns, sepsis and autoimmune disease.</description><identifier>ISSN: 1838-7640</identifier><identifier>EISSN: 1838-7640</identifier><identifier>DOI: 10.7150/thno.17366</identifier><identifier>PMID: 28382156</identifier><language>eng</language><publisher>Australia: Ivyspring International Publisher</publisher><subject>Animals ; Anti-Inflammatory Agents - administration &amp; dosage ; Benzothiazoles - administration &amp; dosage ; Cytoprotection ; Dextrans - administration &amp; dosage ; Mice ; Myocardial Reperfusion Injury - diagnostic imaging ; Myocardial Reperfusion Injury - drug therapy ; Myocardial Reperfusion Injury - pathology ; Nanostructures - administration &amp; dosage ; Nucleic Acids - metabolism ; Optical Imaging ; Quinolines - administration &amp; dosage ; Research Paper ; Theranostic Nanomedicine - methods ; Treatment Outcome</subject><ispartof>Theranostics, 2017-01, Vol.7 (4), p.814-825</ispartof><rights>Ivyspring International Publisher 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c378t-1ef3cc1feec1fea6644ce8a0badf1dc43f08a700338a120ea979aaa5a91fdb813</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381246/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381246/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,725,778,782,883,27911,27912,53778,53780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28382156$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Howard H</creatorcontrib><creatorcontrib>Yuan, Hushan</creatorcontrib><creatorcontrib>Cho, Hoonsung</creatorcontrib><creatorcontrib>Feng, Yan</creatorcontrib><creatorcontrib>Ngoy, Soeun</creatorcontrib><creatorcontrib>Kumar, Anand T N</creatorcontrib><creatorcontrib>Liao, Ronglih</creatorcontrib><creatorcontrib>Chao, Wei</creatorcontrib><creatorcontrib>Josephson, Lee</creatorcontrib><creatorcontrib>Sosnovik, David E</creatorcontrib><title>Theranostic Nucleic Acid Binding Nanoprobe Exerts Anti-inflammatory and Cytoprotective Effects in Ischemic Injury</title><title>Theranostics</title><addtitle>Theranostics</addtitle><description>Extracellular nucleic acids are proinflammatory molecules that have been implicated in a diverse range of diseases. We report here the development of a multivalent nucleic acid scavenging nanoprobe, where the fluorochrome thiazole orange (TO) is conjugated to a polymeric 40 kDa dextran carrier. Dextran-TO (Dex-TO) has nanomolar affinity for mammalian and bacterial nucleic acids and attenuates the production of inflammatory cytokines from activated macrophages exposed to DNA and RNA. Mice with myocardial ischemia reperfusion that were treated with Dex-TO showed a decrease in myocardial macrophage infiltration at 24 hours (p&lt;0.05) and a decrease in infarct size (18% ± 9%, p&lt;0.01) on day 7. Dex-TO allows sites of injury to be identified with fluorescence imaging, while simultaneously exerting an anti-inflammatory and cytoprotective effect. Dex-TO could be of significant diagnostic and therapeutic (theranostic) utility in a broad range of conditions including ischemia, trauma, burns, sepsis and autoimmune disease.</description><subject>Animals</subject><subject>Anti-Inflammatory Agents - administration &amp; dosage</subject><subject>Benzothiazoles - administration &amp; dosage</subject><subject>Cytoprotection</subject><subject>Dextrans - administration &amp; dosage</subject><subject>Mice</subject><subject>Myocardial Reperfusion Injury - diagnostic imaging</subject><subject>Myocardial Reperfusion Injury - drug therapy</subject><subject>Myocardial Reperfusion Injury - pathology</subject><subject>Nanostructures - administration &amp; dosage</subject><subject>Nucleic Acids - metabolism</subject><subject>Optical Imaging</subject><subject>Quinolines - administration &amp; dosage</subject><subject>Research Paper</subject><subject>Theranostic Nanomedicine - methods</subject><subject>Treatment Outcome</subject><issn>1838-7640</issn><issn>1838-7640</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkUFrGzEQhUVoaILjS39A0bEUNpFW613tpeAaNzEY95KexVg7ihV2JUfShvrfV26ckMxhZuB9vBl4hHzh7LrhM3aTds5f80bU9Rm55FLIoqkr9undfkGmMT6yXBUrW95-Jhdl1ko-qy_J0_0OAzgfk9V0M-oe85xr29Gf1nXWPdBNVvfBb5Eu_2JIkc5dsoV1podhgOTDgYLr6OKQjlhCnexzZo3JW6TW0VXUOxyy7co9juFwRc4N9BGnpzkhf34t7xd3xfr37WoxXxdaNDIVHI3QmhvEY4O6riqNEtgWOsM7XQnDJDSMCSGBlwyhbVoAmEHLTbeVXEzIjxff_bgdsNPoUoBe7YMdIByUB6s-Ks7u1IN_VjMheVnV2eDbySD4pxFjUoONGvseHPoxKi5lJVsuqyaj319QHXyMAc3bGc7UMSZ1jEn9jynDX98_9oa-hiL-ASFAkj0</recordid><startdate>20170101</startdate><enddate>20170101</enddate><creator>Chen, Howard H</creator><creator>Yuan, Hushan</creator><creator>Cho, Hoonsung</creator><creator>Feng, Yan</creator><creator>Ngoy, Soeun</creator><creator>Kumar, Anand T N</creator><creator>Liao, Ronglih</creator><creator>Chao, Wei</creator><creator>Josephson, Lee</creator><creator>Sosnovik, David E</creator><general>Ivyspring International Publisher</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20170101</creationdate><title>Theranostic Nucleic Acid Binding Nanoprobe Exerts Anti-inflammatory and Cytoprotective Effects in Ischemic Injury</title><author>Chen, Howard H ; Yuan, Hushan ; Cho, Hoonsung ; Feng, Yan ; Ngoy, Soeun ; Kumar, Anand T N ; Liao, Ronglih ; Chao, Wei ; Josephson, Lee ; Sosnovik, David E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c378t-1ef3cc1feec1fea6644ce8a0badf1dc43f08a700338a120ea979aaa5a91fdb813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Animals</topic><topic>Anti-Inflammatory Agents - administration &amp; dosage</topic><topic>Benzothiazoles - administration &amp; dosage</topic><topic>Cytoprotection</topic><topic>Dextrans - administration &amp; dosage</topic><topic>Mice</topic><topic>Myocardial Reperfusion Injury - diagnostic imaging</topic><topic>Myocardial Reperfusion Injury - drug therapy</topic><topic>Myocardial Reperfusion Injury - pathology</topic><topic>Nanostructures - administration &amp; dosage</topic><topic>Nucleic Acids - metabolism</topic><topic>Optical Imaging</topic><topic>Quinolines - administration &amp; dosage</topic><topic>Research Paper</topic><topic>Theranostic Nanomedicine - methods</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Howard H</creatorcontrib><creatorcontrib>Yuan, Hushan</creatorcontrib><creatorcontrib>Cho, Hoonsung</creatorcontrib><creatorcontrib>Feng, Yan</creatorcontrib><creatorcontrib>Ngoy, Soeun</creatorcontrib><creatorcontrib>Kumar, Anand T N</creatorcontrib><creatorcontrib>Liao, Ronglih</creatorcontrib><creatorcontrib>Chao, Wei</creatorcontrib><creatorcontrib>Josephson, Lee</creatorcontrib><creatorcontrib>Sosnovik, David E</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Theranostics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Howard H</au><au>Yuan, Hushan</au><au>Cho, Hoonsung</au><au>Feng, Yan</au><au>Ngoy, Soeun</au><au>Kumar, Anand T N</au><au>Liao, Ronglih</au><au>Chao, Wei</au><au>Josephson, Lee</au><au>Sosnovik, David E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Theranostic Nucleic Acid Binding Nanoprobe Exerts Anti-inflammatory and Cytoprotective Effects in Ischemic Injury</atitle><jtitle>Theranostics</jtitle><addtitle>Theranostics</addtitle><date>2017-01-01</date><risdate>2017</risdate><volume>7</volume><issue>4</issue><spage>814</spage><epage>825</epage><pages>814-825</pages><issn>1838-7640</issn><eissn>1838-7640</eissn><abstract>Extracellular nucleic acids are proinflammatory molecules that have been implicated in a diverse range of diseases. We report here the development of a multivalent nucleic acid scavenging nanoprobe, where the fluorochrome thiazole orange (TO) is conjugated to a polymeric 40 kDa dextran carrier. Dextran-TO (Dex-TO) has nanomolar affinity for mammalian and bacterial nucleic acids and attenuates the production of inflammatory cytokines from activated macrophages exposed to DNA and RNA. Mice with myocardial ischemia reperfusion that were treated with Dex-TO showed a decrease in myocardial macrophage infiltration at 24 hours (p&lt;0.05) and a decrease in infarct size (18% ± 9%, p&lt;0.01) on day 7. Dex-TO allows sites of injury to be identified with fluorescence imaging, while simultaneously exerting an anti-inflammatory and cytoprotective effect. Dex-TO could be of significant diagnostic and therapeutic (theranostic) utility in a broad range of conditions including ischemia, trauma, burns, sepsis and autoimmune disease.</abstract><cop>Australia</cop><pub>Ivyspring International Publisher</pub><pmid>28382156</pmid><doi>10.7150/thno.17366</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1838-7640
ispartof Theranostics, 2017-01, Vol.7 (4), p.814-825
issn 1838-7640
1838-7640
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5381246
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; PubMed Central
subjects Animals
Anti-Inflammatory Agents - administration & dosage
Benzothiazoles - administration & dosage
Cytoprotection
Dextrans - administration & dosage
Mice
Myocardial Reperfusion Injury - diagnostic imaging
Myocardial Reperfusion Injury - drug therapy
Myocardial Reperfusion Injury - pathology
Nanostructures - administration & dosage
Nucleic Acids - metabolism
Optical Imaging
Quinolines - administration & dosage
Research Paper
Theranostic Nanomedicine - methods
Treatment Outcome
title Theranostic Nucleic Acid Binding Nanoprobe Exerts Anti-inflammatory and Cytoprotective Effects in Ischemic Injury
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T16%3A39%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Theranostic%20Nucleic%20Acid%20Binding%20Nanoprobe%20Exerts%20Anti-inflammatory%20and%20Cytoprotective%20Effects%20in%20Ischemic%20Injury&rft.jtitle=Theranostics&rft.au=Chen,%20Howard%20H&rft.date=2017-01-01&rft.volume=7&rft.issue=4&rft.spage=814&rft.epage=825&rft.pages=814-825&rft.issn=1838-7640&rft.eissn=1838-7640&rft_id=info:doi/10.7150/thno.17366&rft_dat=%3Cproquest_pubme%3E1884891847%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1884891847&rft_id=info:pmid/28382156&rfr_iscdi=true